Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?

Molecular techniques have improved our understanding of the pathogenesis of cancer development. These techniques have also fueled the rational development of targeted drugs for patient populations stratified by their genetic characteristics. These novel methods have changed the classic paradigm of d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Chae, Young Kwang, Arya, Ayush, Chiec, Lauren, Shah, Hiral, Rosenberg, Ari, Patel, Sandip, Raparia, Kirtee, Choi, Jaehyuk, Wainwright, Derek A., Villaflor, Victoria, Cristofanilli, Massimo, Giles, Francis
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725070/
https://ncbi.nlm.nih.gov/pubmed/29246028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19809
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados